Cargando…
Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities
[Image: see text] Cancer cells often have a high demand for antiapoptotic proteins in order to resist programmed cell death. CDK9 inhibition selectively targets survival proteins and reinstates apoptosis in cancer cells. We designed a series of 4-thiazol-2-anilinopyrimidine derivatives with function...
Autores principales: | Shao, Hao, Shi, Shenhua, Huang, Shiliang, Hole, Alison J., Abbas, Abdullahi Y., Baumli, Sonja, Liu, Xiangrui, Lam, Frankie, Foley, David W., Fischer, Peter M., Noble, Martin, Endicott, Jane A., Pepper, Chris, Wang, Shudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579313/ https://www.ncbi.nlm.nih.gov/pubmed/23301767 http://dx.doi.org/10.1021/jm301475f |
Ejemplares similares
-
Comparative Structural
and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile
CDK9 Inhibitors Suggest the Basis for Isotype Selectivity
por: Hole, Alison J., et al.
Publicado: (2012) -
The CDK9 C-helix Exhibits
Conformational Plasticity
That May Explain the Selectivity of CAN508
por: Baumli, Sonja, et al.
Publicado: (2012) -
The CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b
por: Baumli, Sonja, et al.
Publicado: (2012) -
2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK
por: Bung, Navneet, et al.
Publicado: (2018) -
CDK1 structures reveal conserved and unique features of the essential cell cycle CDK
por: Brown, Nicholas R., et al.
Publicado: (2015)